CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure Attenuated plaque detected by intravascular ultrasound: clinical, angiographic, and morphologic features and post-percutaneous coronary intervention complications in patients with acute coronary syndromes Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure Combined use of OCT and IVUS in spontaneous coronary artery dissection

Original Research2021 Jan 12;S0828-282X(21)00005-2.

JOURNAL:Can J Cardiol. Article Link

When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease

E O'Meara, S Verma. Keywords: SGLT2 inhibitors; heart failure; chronic kidney disease

Full Text PDF